Résumé
Recent data demonstrate that secondary necrosis is not an accidental epiphenomenon of apoptosis, but a finely regulated process with prominent pathophysiological and therapeutic implications. The molecular machinery that controls secondary necrosis stands out as a promising target for the development of novel drugs that may increase the immunogenicity of cancer cells succumbing to treatment.
langue originale | Anglais |
---|---|
Pages (de - à) | 1-2 |
Nombre de pages | 2 |
journal | Trends in Cancer |
Volume | 3 |
Numéro de publication | 1 |
Les DOIs | |
état | Publié - 1 janv. 2017 |